Shenzhen New Industries Biomedical Engineering Co., Ltd.

SZSE:300832.SZ

60.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 1,184.5741,017.2551,017.5361,042.92989.325875.859750.279879.766674.076742.835651.534668.175693.335532.371624.591600.274681.349288.753494.598446.791425.068315.13264.301264.301196.951196.951208.378208.378157.463157.463153.99153.99118.648118.648114.982114.98274.07974.079
Cost of Revenue 367.163267.255289.822267.358261274.308207.316260.079231.641207.167170.984203.489205.388154.442156.402143.884115.27285.31199.68384.54490.24962.52657.53557.53540.23740.23750.8850.8838.16438.16438.9638.9626.41826.41833.28633.28619.1719.17
Gross Profit 817.411750727.714775.562728.325601.551542.963619.687442.435535.668480.549464.686487.947377.929468.189456.39566.077203.441394.915362.247334.819252.604206.767206.767156.715156.715157.498157.498119.299119.299115.03115.0392.2392.2381.69681.69654.90954.909
Gross Profit Ratio 0.690.7370.7150.7440.7360.6870.7240.7040.6560.7210.7380.6950.7040.710.750.760.8310.7050.7980.8110.7880.8020.7820.7820.7960.7960.7560.7560.7580.7580.7470.7470.7770.7770.7110.7110.7410.741
Reseach & Development Expenses 92.685101.45686.00599.26688.81283.18794.25991.04373.90858.50172.11757.97344.70140.25436.82833.57252.58727.59633.57929.80529.94126.26523.58623.5860014.02514.0250011.00711.007000000
General & Administrative Expenses -5.55329.28-38.77766.1111.73220.861-65.37683.814-13.56832.612-194.172209.877-73.27787.41-97.58489.6710.34914.133-7.26911.8179.1229.36222.16222.16216.13916.13968.24368.24313.14713.14711118.8448.8448.7598.7598.0148.014
Selling & Marketing Expenses 174.609159.401146.477157.567200.977125.289125.803123.681109.299100.003112.907103.71675.09278.24168.54173.45794.10661.011100.22385.17583.45959.38145.3345.3334.59734.59732.81832.81828.03928.03922.30122.30123.6223.6221.46221.46215.5215.52
SG&A 190.585196.882143.781223.678202.709146.15160.426207.49695.731132.614-81.265313.5931.815165.651-29.044163.12894.45575.14592.95496.99292.58268.74371.03571.03551.96251.962101.227101.22744.55544.55535.22235.22233.68833.68831.46331.46323.53523.535
Other Expenses -17.783-0.306-0.777-0.091-1.036-16.94-33.665-46.26748.767-10.222-0.146-0.029-1.705-0.018-1.38-0.358-0.062-0.001-0.199-0.12-0.097-0.0420000000000000000
Operating Expenses 283.27298.337229.786292.212322.39212.398121.02252.272218.405180.893120.591208.825196.879197.641180.455193.603150.08595.429146.672124.748115.85689.95957.50257.50246.52346.52391.77991.77942.58742.58731.27531.27528.67928.67931.25731.25723.5423.54
Operating Income 534.141451.663497.928501.425459.816405.717442.66407.296294.951358.712366.127275.8292.266203.235286.466258.747426.299127.051247.881257.87232.594160.58134.406134.406103.83103.8354.10454.10473.98373.98378.94378.94357.6357.6349.29949.29930.80230.802
Operating Income Ratio 0.4510.4440.4890.4810.4650.4630.590.4630.4380.4830.5620.4130.4220.3820.4590.4310.6260.440.5010.5770.5470.510.5090.5090.5270.5270.260.260.470.470.5130.5130.4860.4860.4290.4290.4160.416
Total Other Income Expenses Net 19.6834.81829.524-0.091-1.036-0.218-1.326-0.334-0.181-0.576-0.14619.909-0.50822.929-2.649-4.39710.24519.037-0.56120.25113.534-2.10817.5317.538.4528.45213.34113.3414.1614.1615.7775.7776.046.041.2331.2331.0411.041
Income Before Tax 553.82486.48527.452501.334458.78405.499441.334406.962294.769358.137365.981275.771290.561203.217285.086258.389426.237127.05247.682257.75232.497160.538151.936151.936112.282112.28267.44667.44678.14478.14484.7284.7263.6763.6750.53250.53231.84331.843
Income Before Tax Ratio 0.4680.4780.5180.4810.4640.4630.5880.4630.4370.4820.5620.4130.4190.3820.4560.430.6260.440.5010.5770.5470.5090.5750.5750.570.570.3240.3240.4960.4960.550.550.5370.5370.4390.4390.430.43
Income Tax Expense 76.89260.25960.50264.62963.84950.43137.98751.96833.67149.65858.00238.66530.09435.07344.30435.75461.25716.335.42135.83832.09822.522.08622.08616.28516.2859.7119.71111.31911.31911.82311.82310.13110.1316.916.914.8314.831
Net Income 476.928426.221466.949436.705394.931355.068403.347354.994261.099308.478307.979237.106260.467168.145240.782222.636364.98110.75212.261221.912200.399138.038129.85129.8595.99895.99857.73457.73466.82566.82572.89772.89753.5453.5443.62243.62227.01127.011
Net Income Ratio 0.4030.4190.4590.4190.3990.4050.5380.4040.3870.4150.4730.3550.3760.3160.3860.3710.5360.3840.4290.4970.4710.4380.4910.4910.4870.4870.2770.2770.4240.4240.4730.4730.4510.4510.3790.3790.3650.365
EPS 0.610.540.590.560.50.450.510.450.330.390.390.30.330.410.310.280.460.160.30.320.280.20.180.180.140.140.0820.0820.0980.0980.110.110.0780.0780.0640.0640.0390.04
EPS Diluted 0.610.540.590.560.50.450.510.450.330.390.390.30.330.410.310.280.460.160.30.320.280.20.180.180.140.140.0820.0820.0980.0980.110.110.0780.0780.0640.0640.0390.04
EBITDA 586.908487.552547.565482.269463.838398.048424.207413.178295.903366.613359.527272.155311.365166.198289.591262.77419.505110.117249.826242.303227.459164.67142.158142.158111.187111.18760.18860.18879.41879.41880.35480.35459.04559.04550.46850.46831.82831.828
EBITDA Ratio 0.4950.4790.5380.4620.4690.4540.5650.470.4390.4940.5520.4070.4490.3120.4640.4380.6160.3810.5050.5420.5350.5230.5380.5380.5650.5650.2890.2890.5040.5040.5220.5220.4980.4980.4390.4390.430.43